Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23487587 | 0.95 | CHEK1 (0.38) | CHEK1ABCG2HSD11B1HRH4PIK3CD | |
| SCHEMBL22563570 | 0.94 | ABCG2 (0.43) | CHEK1ABCG2IRAK4KMT2AMEN1 | |
| SCHEMBL22563588 | 0.94 | CHEK1 (0.36) | CHEK1ABCG2IRAK4 | |
| SCHEMBL22563560 | 0.92 | IRAK4 (0.36) | CHEK1ABCG2HSD11B1IRAK4 | |
| SCHEMBL22563506 | 0.91 | USP14 (0.38) | ABCG2CRHR1 | |
| SCHEMBL22563500 | 0.91 | ABCG2 (0.41) | CHEK1ABCG2IRAK4KMT2AMEN1 | |
| SCHEMBL23487285 | 0.91 | ABCG2 (0.43) | CHEK1ABCG2IRAK4KMT2AMEN1 | |
| SCHEMBL19909127 | 0.90 | CHEK1 (0.41) | CHEK1HSD11B1HRH4PIK3CDPIK3CA | |
| SCHEMBL21108351 | 0.90 | CHEK1 (0.41) | CHEK1HRH4PIK3CDPIK3CAKMT2A | |
| SCHEMBL23487779 | 0.90 | ABCG2 (0.38) | CHEK1ABCG2IRAK4KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| EP-3580300-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | CHEK1 2408/4885ABCG2 2612/4885HSD11B1 2836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.